Capsules, tablets, or softgels: choosing the right format for a US supplement line

One of the earliest decisions for a US supplement is the delivery format, and it shapes everything downstream — cost, dose, stability, label, and consumer appeal. Capsules, tablets, and softgels each have strengths and constraints, and the right choice depends on the actives and the market position.

Capsules

Two-piece capsules (gelatin or vegetarian) are versatile, quick to formulate, and good for powders and blends. They mask taste well and suit smaller batches, but hold a limited fill weight and can struggle with very high doses or liquids. They're often the fastest, most flexible starting format.

Tablets

Tablets compress powder into a dense form that can carry higher doses in a smaller space and are cheap at scale. But they require binders, disintegrants, and other excipients, demand more formulation work to ensure they break down and release properly, and can be harder to swallow. They suit high-volume, dose-heavy products.

Softgels

Softgels excel at oils and fat-soluble actives, sealing liquids in an airtight shell that protects against oxidation and masks taste. They're premium-feeling but more complex and costly to make, and not suited to large powder doses. For omega oils, vitamin D, or CoQ10, they're often the natural choice.

Matching format to formula

The format has to fit the actives, the target dose, the stability needs, and the brand's positioning — and it determines excipients, the panel, and unit economics. Many lines use different formats for different products. Being able to model the same active in different formats, with the resulting specs and labels, makes that decision faster and better informed.

This is general information, not regulatory or legal advice. US requirements change and turn on specifics, so confirm the current rules with the FDA, FTC, or a qualified US regulatory expert before relying on them.

Where Lemoniq fits

Lemoniq holds each product as one structured formula — ingredients, amounts, specifications, sourcing, and the documentation behind them — and generates what US supplement product development needs from that single source: the Supplement Facts panel, the claim and disclaimer wording, the records that cGMP expects, and the data to back overages, dating, and origin. Compliance becomes a property of the formula, not a pile of separate documents.

The takeaway

The US supplement model trades pre-market approval for full manufacturer responsibility, which means the work shifts onto documentation, accurate labeling, and defensible formulas. The brands that scale in the US are the ones whose single source-of-truth formula generates each label, specification, and record correctly — every time, across every product.

Lemoniq turns one formula into compliant, US-ready outputs — panel, claims, specs, and documentation — from a single source. We solve this exact problem. See how it works